Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Johan Kros"'
Autor:
Youri Hoogstrate, Santoesha Ghisai, Kaspar Draaisma, Vincent Bours, Jan Buter, Isabelle vanden Bempt, Marica Eoli, Enrico Franceschi, Jean-Sebastien Frenel, Thierry Gorlia, Monique Hanse, Ann Hoeben, Melissa Kerkhof, Johan Kros, Sieger Leenstra, Guiseppe Lombardi, Slávka Lukacova, Pierre Robe, Juan M. Sepulveda, Walter Taal, Martin Taphoorn, Annemiek M.E. Walenkamp, Colin Watts, Michael Weller, Filip Y.F. de Vos, Martin van den Bent, Pim French
Publikováno v:
WFNOS 2022 Abstract Book.
Autor:
Wies Vallentgoed, Anneke Niers, Karin van Garderen, Martin van den Bent, Kaspar Draaisma, Iris de Heer, Mathilde Kouwenhoven, Johan Kros, Ivonne Martin, Pierre Robe, Marion Smits, Mircea Tesileanu, Hinke van Thuijl, Roel Verhaak, Bart Westerman, Mark van de Wiel, Bauke Ylstra, Wendy de Leng, Pieter Wesseling, Pim French
Publikováno v:
Neuro Oncol
The GLASS-NL consortium, was initiated to gain insight into the molecular mechanisms underlying glioma evolution and to identify markers of progression in IDH-mutant astrocytomas. Here, we present the first results of genome-wide DNA-methylation prof
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3f6f2da9c84b5f5bb8102da0387457c
https://europepmc.org/articles/PMC8598565/
https://europepmc.org/articles/PMC8598565/
Autor:
Thijs van der Vaart, Karin van Garderen, Maarten Wijnenga, Erik Jan Dubbink, Pim French, Marion Smits, Clemens M F Dirven, Johan Kros, Arnaud Vincent, Martin van den Bent
Publikováno v:
Neuro-Oncology. 24:vii255-vii255
BACKGROUND Evidence suggests that smaller residual tumor volumes after initial surgery are associated with longer survival in patients with astrocytoma, IDH-mutant, grade II. For IDH-mutant glioma of higher grade but also for oligodendroglioma, IDH-m
Autor:
Wies Rijan Vallentgoed, Anneke Niers, Karin van Garderen, Martin van den Bent, Erik van Dijk, Kaspar Draaisma, Paul van Eijk, Iris de Heer, Mathilde Kouwenhoven, Johan Kros, Wendy de Leng, Ivonne Martin, Pierre Robe, Marion Smits, Mircea Tesileanu, Hinke van Thuijl, Roel Verhaak, Bart Westerman, Mark van de Wiel, Bauke Ylstra, Pieter Wesseling, Pim French
Publikováno v:
Cancer Research. 82:4020-4020
INTRODUCTION. Diffuse gliomas are the most frequent and devastating primary CNS tumors in adults. Standard treatment has limited efficacy and without exception these gliomas recur. The evolutionary processes that drive progression in glioma of the ID
Autor:
Mircea Tesileanu, Pim French, Marc Sanson, Alba Ariela Brandes, Wolfgang Wick, Paul Clement, Johan Kros, Thierry Gorlia, Vassilis Golfinopoulos, Martin van den Bent
Publikováno v:
Neuro-Oncology. 23:vi120-vi121
BACKGROUND Temozolomide efficacy in high-grade glioma is related to MGMTp methylation. We compared the prognostic and predictive effect of MGMTp between DNA methylation profiling (MGMT-STP27 model) and qMS-PCR in IDH1/2mt anaplastic astrocytoma patie
Autor:
Kaspar Draaisma, Aikaterini Chatzipli, Martin Taphoorn, Melissa Kerkhof, Astrid Weyerbrock, Marc Sanson, Ann Hoeben, Lukacova Slavka, Giuseppe Lombardi, Monique Hanse, Ruth Fleischeuer, Sieger Leenstra, Colin Watts, Thierry Gorlia, Vassilis Golfinopoulos, Johan Kros, Martin van den Bent, Ultan McDermott, Pierre Robe, Pim French
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e8abc72632d9437854bf3860d58d94c
https://europepmc.org/articles/PMC5692847/
https://europepmc.org/articles/PMC5692847/
Autor:
Maarten Wijnenga, Pim French, Hendrikus Dubbink, Winand Dinjens, Peggy Atmodimedjo, Johan Kros, Marion Smits, Renske Gahrmann, Geert-Jan Rutten, Jeroen Verheul, Ruth Fleischeuer, Clemens Dirven, Arnaud Vincent, Martin van den Bent
Publikováno v:
Neuro-Oncology. 19:vi236-vi236
Autor:
Ch.J. Vecht, J.M. (Johan) Kros, J. Ma, Cees C. Tijssen, Rob L. H. Jansen, Olaf Loosveld, J.H.M. Schellens, P A E Sillevis Smit, M. J. van den Bent, Jaap Verweij
Publikováno v:
European Journal of Cancer, 34(10), 1570-1574. Elsevier Ltd.
27 patients with recurrent high grade glioma following surgery and radiation therapy were treated with 100 mg/m2 cisplatin and 6 g/m2 ifosfamide per cycle, administered on days 1-3 in 4 week cycles, for a maximum of six cycles. Toxicity was assessed
Publikováno v:
Journal of Neuropathology and Experimental Neurology, 56(10), 1125-1131. Oxford University Press
Journal of neuropathology and experimental neurology, 56(10), 1125-1131. Lippincott Williams and Wilkins
Journal of neuropathology and experimental neurology, 56(10), 1125-1131. Lippincott Williams and Wilkins
Recently, lineage-specific genetic pathways of tumor progression have been suggested in both oligodendrogliomas and astrocytomas. Aberrations consistently reported in gliomas include chromosomes 1, 7, 10, 17 and 19. Identification of specific genetic